Regulation of osteoblast differentiation mediated by BMP, Notch, and CCN3/NOV

Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 Yamaguchi, 1991, Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro, J Cell Biol, 113, 681, 10.1083/jcb.113.3.681 Yamaguchi, 2000, Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1, Endocr Rev, 21, 393, 10.1210/edrv.21.4.0403 Katagiri, 1994, Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage, J Cell Biol, 127, 1755, 10.1083/jcb.127.6.1755 Urist, 1965, Bone: formation by autoinduction, Science, 150, 893, 10.1126/science.150.3698.893 Ducy, 1997, Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation, Cell, 89, 747, 10.1016/S0092-8674(00)80257-3 Lee, 2000, Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12, Mol Cell Biol, 20, 8783, 10.1128/MCB.20.23.8783-8792.2000 Lee, 2003, BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression, J Biol Chem, 278, 34387, 10.1074/jbc.M211386200 Celil, 2005, BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways, J Biol Chem, 280, 31353, 10.1074/jbc.M503845200 Lee, 2003, BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2, Biochem Biophys Res Commun, 309, 689, 10.1016/j.bbrc.2003.08.058 Komori, 1997, Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts, Cell, 89, 755, 10.1016/S0092-8674(00)80258-5 Otto, 1997, Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development, Cell, 89, 765, 10.1016/S0092-8674(00)80259-7 Nakashima, 2002, The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation, Cell, 108, 17, 10.1016/S0092-8674(01)00622-5 Bolos, 2007, Notch signaling in development and cancer, Endocr Rev, 28, 339, 10.1210/er.2006-0046 Fiuza, 2007, Cell and molecular biology of Notch, J Endocrinol, 194, 459, 10.1677/JOE-07-0242 Dahlqvist, 2003, Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation, Development, 130, 6089, 10.1242/dev.00834 Itoh, 2004, Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells, EMBO J, 23, 541, 10.1038/sj.emboj.7600065 Herpin, 2007, Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes, FEBS J, 274, 2977, 10.1111/j.1742-4658.2007.05840.x Nobta, 2005, Critical regulation of BMP-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling, J Biol Chem, 280, 15842, 10.1074/jbc.M412891200 Nofziger, 1999, Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts, Development, 126, 1689, 10.1242/dev.126.8.1689 Tezuka, 2002, Stimulation of osteoblastic cell differentiation by Notch, J Bone Miner Res, 17, 231, 10.1359/jbmr.2002.17.2.231 Sciaudone, 2003, Notch 1 impairs osteoblastic cell differentiation, Endocrinology, 144, 5631, 10.1210/en.2003-0463 Deregowski, 2006, Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling, J Biol Chem, 281, 6203, 10.1074/jbc.M508370200 Sakamoto, 2002, The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway, J Biol Chem, 277, 29399, 10.1074/jbc.M203727200 Calhabeu, 2006, NOV/CCN3 impairs muscle cell commitment and differentiation, Exp Cell Res, 312, 1876, 10.1016/j.yexcr.2006.02.027 Takigawa, 2003, Role of CTGF/HCS24/ecogenin in skeletal growth control, J Cell Physiol, 194, 256, 10.1002/jcp.10206 Lafont, 2005, New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen, J Bone Miner Res, 20, 2213, 10.1359/JBMR.050818 Nishida, 2000, Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro, J Cell Physiol, 184, 197, 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R Luo, 2004, Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells, J Biol Chem, 279, 55958, 10.1074/jbc.M407810200 Si, 2006, CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells, Mol Cell Biol, 26, 2955, 10.1128/MCB.26.8.2955-2964.2006 Minamizato, 2007, CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways, Biochem Biophys Res Commun, 354, 567, 10.1016/j.bbrc.2007.01.029 Abreu, 2002, Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta, Nat Cell Biol, 4, 599, 10.1038/ncb826 Heldin, 1997, TGF-beta signaling from cell membrane to nucleus through SMAD proteins, Nature, 390, 465, 10.1038/37284 Rosenzweig, 1995, Cloning and characterization of a human type II receptor for bone morphogenetic proteins, Proc Natl Acad Sci USA, 92, 7632, 10.1073/pnas.92.17.7632 Nohno, 1995, Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors, J Biol Chem, 270, 22522, 10.1074/jbc.270.38.22522 Massaous, 1997, TGF-beta signaling through the Smad pathway, Trends Cell Biol, 7, 187, 10.1016/S0962-8924(97)01036-2 Leivonen, 2007, Transforming growth factor-β signaling in cancer invasion and metastasis, Int J Cancer, 121, 2119, 10.1002/ijc.23113 Hoodless, 1996, MADR1, a MAD-related protein that functions in BMP2 signaling pathway, Cell, 85, 489, 10.1016/S0092-8674(00)81250-7 Graff, 1996, Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily, Cell, 85, 479, 10.1016/S0092-8674(00)81249-0 Liu, 1996, A human Mad protein acting as a BMP-regulated transcriptional activator, Nature, 381, 620, 10.1038/381620a0 Kretzschmar, 1997, The TGF-β family mediator Smad1 is phospholyrated directly and activated functionally by the BMP receptor kinase, Genes Dev, 11, 984, 10.1101/gad.11.8.984 Zhang, 1996, Receptor-associated Mad homologues synergize as effectors of TGF-β response, Nature, 383, 168, 10.1038/383168a0 Hayashi, 1997, The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling, Cell, 89, 1165, 10.1016/S0092-8674(00)80303-7 Imamura, 1997, Smad6 inhibits signaling by the TGF-β superfamily, Nature, 389, 622, 10.1038/39355 Hata, 1998, Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor, Genes Dev, 12, 186, 10.1101/gad.12.2.186 Canalis, 2003, Bone morphogenetic proteins, their antagonists, and the skeleton, Endocr Rev, 24, 218, 10.1210/er.2002-0023 Zimmerman, 1996, The Spemann organizer signal noggin bonds and inactivates bone morphogenetic protein 4, Cell, 86, 599, 10.1016/S0092-8674(00)80133-6 Piccolo, 1996, Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4, Cell, 86, 589, 10.1016/S0092-8674(00)80132-4 Hsu, 1998, The Xenopus dorsaling factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities, Mol Cell, 1, 673, 10.1016/S1097-2765(00)80067-2 Brunet, 1998, Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton, Science, 280, 1455, 10.1126/science.280.5368.1455 Katagiri, 1990, The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2, Biochem Biophy Res Commun, 172, 295, 10.1016/S0006-291X(05)80208-6 Asahina, 1996, Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells, Exp Cell Res, 222, 38, 10.1006/excr.1996.0005 Yamaguchi, 1991, Clonal osteogenic cell lines express myogenic and adipocytic developmental potential, Calcif Tissue Int, 49, 221, 10.1007/BF02556122 Wada, 1998, Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvarial cells, Bone, 22, 479, 10.1016/S8756-3282(98)00039-8 Tsuji, 2006, BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing, Nat Genet, 38, 1424, 10.1038/ng1916 Lubman, 2004, Anchoring notch genetics and biochemistry; structural analysis of the ankyrin domain sheds light on existing data, Mol Cell, 13, 619, 10.1016/S1097-2765(04)00120-0 Sakamoto, 2005, Distinct roles of EGF repeats for the Notch signaling system, Exp Cell Res, 302, 281, 10.1016/j.yexcr.2004.09.016 Sestan, 1999, Contact-dependent inhibition of cortical neurite growth mediated by notch signaling, Science, 286, 741, 10.1126/science.286.5440.741 Hansson, 2004, Notch signaling in development and disease, Semin Cancer Biol, 14, 320, 10.1016/j.semcancer.2004.04.011 Shindo, 2003, Osteogenic differentiation of the mesenchymal progenitor cells, Kusa is suppressed by Notch signalling, Exp Cell Res, 290, 370, 10.1016/S0014-4827(03)00349-5 Blokzijl, 2003, Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3, J Cell Biol, 163, 723, 10.1083/jcb.200305112 Takizawa, 2003, Enhanced gene activation by Notch and BMP signaling cross-talk, Nucleic Acids Res, 31, 5723, 10.1093/nar/gkg778 de Jong, 2004, Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells, Biochem Biophys Res Commun, 320, 100, 10.1016/j.bbrc.2004.05.150 Zamurovic, 2004, Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity, J Biol Chem, 279, 37704, 10.1074/jbc.M403813200 Perbal, 1999, The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling, Proc Natl Acad Sci USA, 96, 869, 10.1073/pnas.96.3.869 Perbal, 2001, The CCN family of genes: a brief history, Mol Pathol, 54, 103, 10.1136/mp.54.2.103 Gupta, 2001, Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV), Mol Pathol, 54, 293, 10.1136/mp.54.5.293 Natarajan, 2000, Mouse Nov gene is expressed in hypaxial musculature and cranial structures derived from neural crest cells and placodes, Dev Dyn, 219, 417, 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1058>3.0.CO;2-2 Crowe, 1999, Delta-1 negatively regulates the transition from prehypertrophic to hypertrophic chondrocytes during cartilage formation, Development, 126, 987, 10.1242/dev.126.5.987 Kocialkowski, 2001, Expression of the human NOV gene in first trimester fetal tissues, Anat. Embryol, 203, 417, 10.1007/s004290100177 Lindner, 2001, Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell–cell interaction, Am J Pathol, 159, 875, 10.1016/S0002-9440(10)61763-4 Ellis, 2000, Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury, Arterioscler Thromb Vasc Biol, 20, 1912, 10.1161/01.ATV.20.8.1912 Lee, 2006, HES1 cooperates with pRb to activate RUNX2-dependent transcription, J Bone Miner Res, 21, 921, 10.1359/jbmr.060303 Rydziel, 2007, Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia, J Biol Chem, 282, 19762, 10.1074/jbc.M700212200 Gupta, 2007, NOV(CCN3) functions as a regulator of human hematopoietic stem or progenitor cell, Science, 316, 590, 10.1126/science.1136031 Arai, 2004, Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche, Cell, 118, 149, 10.1016/j.cell.2004.07.004 Wozney, 1988, Novel regulators of bone formation: molecular clones and activities, Science, 242, 1528, 10.1126/science.3201241